<DOC>
	<DOC>NCT01228552</DOC>
	<brief_summary>The purpose of this study is to evaluate the efficacy and safety of intra-oral topical ketoprofen for the treatment of acute migraine.</brief_summary>
	<brief_title>The Efficacy and Safety of Intra-oral Topical Ketoprofen for the Treatment of Acute Migraine</brief_title>
	<detailed_description />
	<mesh_term>Headache</mesh_term>
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Ketoprofen</mesh_term>
	<criteria>Established diagnosis of Migraine as per IHS with aura Established diagnosis of Migraine as per IHS without aura At least 2 migraines per month At least 18 years of age Pregnancy or Lactation Other Headache Conditions including basilar, hemiplegic, or ophthalmoplegic migraines Chronic Daily Headache Allergy or Sensitivity to NSAIDs Other Severe Medical Conditions including GI bleeding, blood dyscrasias, thrombocytopenia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>Acute Migraine Treatment</keyword>
	<keyword>Migraine Treatment</keyword>
	<keyword>Migraine</keyword>
	<keyword>Headache</keyword>
	<keyword>Treatment</keyword>
</DOC>